BG99863A - Antagonists of fibrogenous receptor - Google Patents

Antagonists of fibrogenous receptor

Info

Publication number
BG99863A
BG99863A BG99863A BG9986395A BG99863A BG 99863 A BG99863 A BG 99863A BG 99863 A BG99863 A BG 99863A BG 9986395 A BG9986395 A BG 9986395A BG 99863 A BG99863 A BG 99863A
Authority
BG
Bulgaria
Prior art keywords
receptor
fibrogenous
antagonists
compounds
formula
Prior art date
Application number
BG99863A
Other languages
Bulgarian (bg)
English (en)
Inventor
David Claremon
John Baldwin
Nigel Liverton
Ben Askew
Original Assignee
John Baldwin
Nigel Liverton
Ben Askew
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Baldwin, Nigel Liverton, Ben Askew, Merck & Co. Inc. filed Critical John Baldwin
Publication of BG99863A publication Critical patent/BG99863A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
BG99863A 1993-02-22 1995-08-15 Antagonists of fibrogenous receptor BG99863A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051793A 1993-02-22 1993-02-22
PCT/US1994/001881 WO1994018981A1 (en) 1993-02-22 1994-02-22 Fibrinogen receptor antagonists

Publications (1)

Publication Number Publication Date
BG99863A true BG99863A (en) 1996-02-29

Family

ID=21799049

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99863A BG99863A (en) 1993-02-22 1995-08-15 Antagonists of fibrogenous receptor

Country Status (15)

Country Link
EP (1) EP0684823A4 (sv)
JP (1) JP3173792B2 (sv)
KR (1) KR960700722A (sv)
CN (1) CN1118139A (sv)
AU (1) AU680240B2 (sv)
BG (1) BG99863A (sv)
CA (1) CA2155123A1 (sv)
CZ (1) CZ210895A3 (sv)
FI (1) FI953916A0 (sv)
HU (1) HUT71796A (sv)
NO (1) NO953270L (sv)
NZ (1) NZ262664A (sv)
PL (1) PL310386A1 (sv)
SK (1) SK102495A3 (sv)
WO (1) WO1994018981A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
ES2161373T3 (es) * 1995-08-30 2001-12-01 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas.
DE69633245T2 (de) 1995-09-29 2005-09-08 Eli Lilly And Co., Indianapolis Spiroverbindungen als Inhibitoren der Fibrinogen-abhängigen Blutplättchenaggregation
EP0939757A1 (en) * 1995-12-22 1999-09-08 Dupont Pharmaceuticals Company Novel integrin receptor antagonists
AU2340997A (en) * 1996-03-27 1997-10-17 Merck & Co., Inc. A method for inhibiting clot formation
KR100504449B1 (ko) * 1996-07-25 2005-07-29 바이오겐 아이덱 엠에이 인코포레이티드 세포 유착 억제제
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists
DE19653647A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
EP1023295A4 (en) * 1997-02-06 2001-01-24 Merck & Co Inc PRODUCTS BY FIBRINOGEN RECEPTOR ANTAGONISTS
WO1998043962A1 (en) * 1997-03-28 1998-10-08 Du Pont Pharmaceuticals Company Heterocyclic integrin inhibitor prodrugs
US6303625B1 (en) 1998-07-27 2001-10-16 Ortho-Mcneil Pharmaceutical, Inc. Triazolopyridines for the treatment of thrombosis disorders
IL147495A0 (en) * 1999-07-28 2002-08-14 Aventis Pharm Prod Inc Substituted oxoazaheterocycclyl compounds
RU2005119173A (ru) * 2002-12-20 2006-02-27 Фармация Корпорейшн (Us) Ациклические пиразольные соединения
US20100035756A1 (en) * 2006-07-12 2010-02-11 Syngenta Limited Triazolophyridine derivatives as herbicides
US8088792B2 (en) * 2008-04-04 2012-01-03 Gilead Sciences, Inc. Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors
WO2010096722A1 (en) * 2009-02-20 2010-08-26 Takeda Pharmaceutical Company Limited 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5166154A (en) * 1989-10-17 1992-11-24 Boehringer Ingelheim Pharmaceuticals, Inc. Imidazo[1,2-a]piperazines
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors

Also Published As

Publication number Publication date
NO953270D0 (no) 1995-08-21
FI953916A (sv) 1995-08-21
JP3173792B2 (ja) 2001-06-04
WO1994018981A1 (en) 1994-09-01
EP0684823A4 (en) 1997-07-09
FI953916A0 (sv) 1995-08-21
EP0684823A1 (en) 1995-12-06
CZ210895A3 (en) 1996-02-14
CA2155123A1 (en) 1994-09-01
HU9502028D0 (en) 1995-09-28
AU680240B2 (en) 1997-07-24
CN1118139A (zh) 1996-03-06
AU6246594A (en) 1994-09-14
HUT71796A (en) 1996-02-28
NZ262664A (en) 1997-04-24
NO953270L (no) 1995-10-19
PL310386A1 (en) 1995-12-11
JPH08507072A (ja) 1996-07-30
SK102495A3 (en) 1997-01-08
KR960700722A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
BG99863A (en) Antagonists of fibrogenous receptor
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
TR200000333T2 (tr) Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler.
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
MX9101311A (es) Antagonistas receptores de fibrinogeno
DE69130614T2 (de) Herbizide, substituierte aryl-haloalkylpyrazole
ATE293609T1 (de) Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
NO980553L (no) Endotelinantagonist
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
SE9702773D0 (sv) Novel compounds
FI921345A0 (fi) Piperidinderivat.
DE69426452D1 (de) Fibrinogen receptor antagonisten
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
FI863836A0 (fi) Kinolinderivat.
ES2156255T3 (es) Procedimiento para preparar antagonistas del receptor de fibrinogeno.
MX9300742A (es) Derivados de quinolina substituidos con bifenilo y composicion farmaceutica que los contiene.
ES2099879T3 (es) 5-oxo-dibenzo(a,d)ciclohepta-1,4-dienos y su uso como agentes retrovirales.
DK0566175T3 (da) 3,4-diaryl-(5H)-furan-2-on-baserede forbindelser med fungicid aktivitet
ATE188692T1 (de) Fibrinogenrezeptorantagonisten
KR950700305A (ko) 칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists)
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
SU1610823A1 (ru) S-трет-бутилтиуронийбромид, обладающий антиишемической активностью